(Pyridin-4-yl)boronic acid → 2-Amino-4-methyl-7-(2-pyridin-4-yl-phenyl)-7,8-dihydro-6H-quinazolin-5-one
Reaction equation
CC1C2C(=O)CCCC=2N=CN=1.[N:13]1[CH:18]=[CH:17][C:16](B(O)O)=[CH:15][CH:14]=1.[NH2:22][C:23]1[N:32]=[C:31]([CH3:33])[C:30]2[C:29](=[O:34])[CH2:28][CH:27]([C:35]3[CH:40]=[CH:39][CH:38]=[CH:37][C:36]=3C3C=CC=CC=3)[CH2:26][C:25]=2[N:24]=1>>[NH2:22][C:23]1[N:32]=[C:31]([CH3:33])[C:30]2[C:29](=[O:34])[CH2:28][CH:27]([C:35]3[CH:40]=[CH:39][CH:38]=[CH:37][C:36]=3[C:16]3[CH:17]=[CH:18][N:13]=[CH:14][CH:15]=3)[CH2:26][C:25]=2[N:24]=1Participants
4
Procedure
The title compound was prepared from 2-amino-4-methyl-7-(2-bromo-phenyl), 4-methyl-7,8-dihydro-6H-quinazolin-5-one (example 3/i) and pyridin-4-yl-boronic acid, following the procedure describing the synthesis of 2-amino-7-biphenyl-2-yl-4-methyl-7,8-dihydro-6H-quinazolin-5-one (example 5/a stage 1).
Sources & evidence
- ORD record
- ord-165da59281c14642ad91bbf6c604df75
- Source dataset
- uspto-grants-2013_11
- Patent number
- US08592430B2
Reaction notes
Loading…